ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 84 filers reported holding ARGENX SE in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $58,581,110 | -11.0% | 136,222 | -18.5% | 0.02% | -14.3% |
Q1 2024 | $65,788,029 | -0.7% | 167,093 | -4.1% | 0.02% | -32.3% |
Q4 2023 | $66,280,638 | -26.2% | 174,226 | -4.6% | 0.03% | -32.6% |
Q3 2023 | $89,805,172 | -6.4% | 182,668 | -25.8% | 0.05% | 0.0% |
Q2 2023 | $95,994,789 | +4.4% | 246,311 | -0.1% | 0.05% | 0.0% |
Q1 2023 | $91,907,509 | +14.9% | 246,679 | +16.9% | 0.05% | +9.5% |
Q4 2022 | $79,972,907 | +7.2% | 211,105 | -0.1% | 0.04% | +2.4% |
Q3 2022 | $74,623,000 | -21.4% | 211,366 | -15.7% | 0.04% | -12.8% |
Q2 2022 | $94,969,000 | +19.9% | 250,658 | -0.2% | 0.05% | +46.9% |
Q1 2022 | $79,226,000 | +67.2% | 251,266 | +85.7% | 0.03% | +88.2% |
Q4 2021 | $47,375,000 | +15.9% | 135,284 | -0.0% | 0.02% | +13.3% |
Q3 2021 | $40,859,000 | +0.7% | 135,295 | +0.4% | 0.02% | -6.2% |
Q2 2021 | $40,584,000 | +19.6% | 134,797 | +9.4% | 0.02% | +14.3% |
Q1 2021 | $33,935,000 | -44.0% | 123,223 | -40.2% | 0.01% | -46.2% |
Q4 2020 | $60,564,000 | +3.8% | 205,937 | -7.4% | 0.03% | -7.1% |
Q3 2020 | $58,364,000 | -59.7% | 222,318 | -60.2% | 0.03% | -62.7% |
Q2 2020 | $144,893,000 | +91.5% | 558,786 | -2.7% | 0.08% | +47.1% |
Q1 2020 | $75,673,000 | -24.4% | 574,455 | -7.9% | 0.05% | -3.8% |
Q4 2019 | $100,160,000 | +69.2% | 623,968 | +20.1% | 0.05% | +65.6% |
Q3 2019 | $59,205,000 | -19.5% | 519,527 | +0.0% | 0.03% | -17.9% |
Q2 2019 | $73,523,000 | +20.1% | 519,304 | +5.9% | 0.04% | +18.2% |
Q1 2019 | $61,210,000 | +20.6% | 490,303 | -7.2% | 0.03% | +6.5% |
Q4 2018 | $50,745,000 | +11.4% | 528,216 | -12.1% | 0.03% | +34.8% |
Q3 2018 | $45,559,000 | +11.5% | 600,721 | +21.9% | 0.02% | +9.5% |
Q2 2018 | $40,843,000 | +12.2% | 492,921 | +8.9% | 0.02% | +16.7% |
Q1 2018 | $36,407,000 | +26.0% | 452,600 | -1.1% | 0.02% | +28.6% |
Q4 2017 | $28,893,000 | +267.9% | 457,600 | +30.7% | 0.01% | +250.0% |
Q3 2017 | $7,854,000 | +5.8% | 350,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $7,424,000 | – | 350,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |